Abstract
Background:
Leukocytospermia (LCS) is commonly identified during male infertility evaluation and is associated with impaired semen quality. However, the specific roles of various inflammatory conditions in LCS remain incompletely understood.
Methods:
This cross-sectional study enrolled 9345 males who attended an andrology clinic during the period from April 2020 to March 2023. Demographic and lifestyle factors, medical history, and clinically defined urogenital inflammatory conditions (epididymitis, prostatitis, orchitis, and seminal vesiculitis) were obtained from questionnaires and clinical records. LCS was defined as >1 × 106 peroxidase-positive leukocytes/mL of semen. Multivariable logistic regression models were used to assess associations with LCS and to estimate odds ratios (ORs) and 95% confidence intervals (CIs).
Results:
Of the 9345 men, 1068 (11.4%) had LCS. Men with LCS were slightly older and were more often smokers. Epididymitis (1.69% vs 0.85%, PÂ =Â 0.007) and prostatitis (14.42% vs 10.61%, P < 0.001) were more common in men with LCS. Men with LCS also had lower semen volume, sperm concentration, progressive motility, total motility, total motile sperm count, and normal morphology, and higher sperm DNA fragmentation index and high DNA stainability. In the fully adjusted model, epididymitis (aOR = 1.88, 95% CI 1.10-3.21) and prostatitis (aOR = 1.37, 95% CI 1.14-1.66) were associated with higher odds of LCS. Estimates for orchitis and seminal vesiculitis were imprecise because these conditions were uncommon.
Conclusions:
Epididymitis and prostatitis were associated with higher odds of LCS in men attending an andrology clinic. Our study findings support assessment of urogenital inflammatory conditions in men with LCS.
Introduction
Male infertility is a common clinical challenge, and semen analysis remains central to the evaluation of male reproductive function. Leukocytospermia, characterized as the presence of more than one million leukocytes per milliliter of semen by World Health Organization (WHO) guidelines, is usually linked with male infertility. Clinical studies have reported that approximately 10-30% of infertile men exhibit leukocytospermia (Bai et al., 2021; Assidi, 2022; Rivero et al., 2023). The presence of elevated leukocyte levels in semen is associated with a decrease in semen quality (Fan et al., 2023). Leukocytes in the semen, particularly neutrophils, release a variety of enzymes, cytokines, and reactive oxygen species (ROS) that can damage sperm DNA, and mitochondria (Fariello et al., 2009). This damage can lead to reduced sperm motility, abnormal morphology, and decreased sperm viability (Fraczek et al., 2016). Additionally, studies have shown that men with high semen leukocyte counts tend to have lower fertilization rates in in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) procedures (Sukcharoen et al., 1995; Moilanen et al., 1998).
Urogenital infection and inflammation are related but are not synonymous. Sexually transmitted and urinary pathogens, including Chlamydia trachomatis, Neisseria gonorrhoeae, and enteric bacteria, may cause inflammatory conditions such as epididymitis or bacterial prostatitis (Bai et al., 2022). However, male genital tract inflammation may also occur without microbiologically confirmed infection. The relationship between urogenital tract inflammation (e.g., epididymitis, prostatitis, and urethritis) and leukocytes in semen is a critical area of study in male infertility (Sharma et al., 2022; Fan et al., 2023). Inflammatory stimuli can recruit and activate leukocytes in the male genital tract and increase the number of peroxidase-positive leukocytes in semen. Once the concentration exceeds the WHO threshold, LCS is present. Inflammatory processes lead to the release of ROS and pro-inflammatory cytokines (e.g., TNF-α, IL-6, IL-8) by leukocytes, which impair sperm membrane integrity, motility, and DNA quality (Haidl et al., 2015). Common inflammatory conditions, such as prostatitis (prevalence of 4% to 11% in men under 50) and epididymitis, can spread to the testis as ‘epididymo-orchitis’, leading to spermatogenic impairment, testicular atrophy, or even arrest of spermatogenesis (Nickel et al., 2001; Choi et al., 2020). These inflammatory conditions are strongly linked to male infertility, with studies indicating that 15% of infertile men exhibit signs of reproductive tract infection (Pellati et al., 2008). Since research has established a link between urogenital tract inflammation and leukocyte levels in semen, studies on the correlation between different types of urogenital inflammation and leukocytospermia remain unknown.
Age, smoking, chronic systemic disease, and other clinical factors may also be associated with seminal leukocyte concentrations (Ilacqua et al., 2018; Dutta et al., 2025; Gill et al., 2024). The aim of this study was therefore to assess the associations between clinically defined epididymitis, prostatitis, orchitis, and seminal vesiculitis and LCS in men attending an andrology clinic. We also compared semen parameters between men with and without LCS.
Methods
Participants
This is a cross-sectional study included 12,791 clinical records with semen analysis data from men attending the andrology clinic between April 2020 and March 2023 (Figure 1). We excluded 2903 records because of incomplete clinical information, 241 repeated semen-analysis records, 203 records from men with azoospermia, 87 records from men with genetic abnormalities, and 12 records from men with cryptorchidism. The final analytical sample comprised 9345 men, with one semen-analysis record and one questionnaire per participant.
Figure 1
The inclusion criteria were as follows: (1) 18 years of age or older and (2) no antibiotic treatment within the preceding two weeks. At the clinical visit, participants completed a standardized questionnaire covering smoking, alcohol consumption, educational level, sexual frequency, duration of infertility, and medical history. Clinical information, including chronic systemic disease, varicocele, redundant foreskin, cryptorchidism, and previous genital surgery, was obtained from the questionnaire and clinical records. The study protocol was approved by the Institutional Review Board (Approval No. 2023-RE-196) and is reported according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement.
Urogenital inflammatory conditions included chronic epididymitis, prostatitis, orchitis, and seminal vesiculitis. Chronic epididymitis was defined by unilateral or bilateral epididymal pain or discomfort for the previous 3 months together with induration, irregularity, or thickening on clinical examination. Prostatitis was defined by persistent pain in the prostate region at least three months, with urinary and/or sexual symptoms during the previous 3 months. Orchitis was identified by unilateral or bilateral testicular swelling, atrophy, or pain, with fever or scrotal erythema during the previous 3 months. Seminal vesiculitis was identified by hematospermia, painful ejaculation, and perineal or lower abdominal discomfort during the previous 3 months.
Semen analysis
Semen samples were collected via masturbation after abstinence of 2–7 days. All analyses were performed in accordance with the fifth edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen (World Health Organization, 2010). After collection, each sample was placed in a 37 °C incubator for ≥30 min to ensure complete liquefaction before any manipulation. Sperm concentration, progressive motility, total motility, and detailed kinematic variables were quantified using a computer-assisted sperm analyzer (CASA; SAS-II, SAS Medical, Beijing, China) that had been calibrated with latex beads of known concentration and motility. The total motile sperm count (TMSC) was computed as: TMSC = ejaculate volume (mL) × sperm concentration (×106/mL) × progressive motility (%). Sperm morphology was assessed after Diff-Quik staining (Anke Biotechnology, Hefei, China). A minimum of 200 spermatozoa per specimen were examined at 1 000× magnification under oil immersion. Leukocyte quantification in seminal plasma was carried out by peroxidase staining with benzidine (Anke Biotechnology) and expressed as ×106 cells/mL. The presence of anti-sperm antibodies (AsAs) was determined by the mixed antiglobulin reaction (MAR) test (Anke Biotechnology) following the manufacturer’s protocol. The sperm DNA fragmentation index (DFI) and high DNA stainability (HDS) were evaluated by the sperm chromatin structure assay (SCSA; Celula, Chengdu, China) on an Accuri C6 flow cytometer (BD Biosciences). All technicians received standardized training in semen collection, handling, and analysis procedures provided by the National Research Institute for Family Planning. The laboratory participates continuously in the External Quality Assessment (EQA) program coordinated by the NHC Key Laboratory of Male Reproduction and Genetics.
Statistical analysis
Categorical variables are expressed as counts and proportions, whereas continuous variables are presented as the mean ± standard deviation (SD) when normally distributed or as the median with interquartile range (IQR) otherwise. Normality was assessed with the Shapiro-Wilk test. Between-group comparisons of categorical data were performed with Pearson’s chi-square test. Differences in continuous variables were evaluated using the two-sample Student t test (parametric) or the Mann-Whitney U test (non-parametric), as appropriate. Logistic regression models were used to assess associations with LCS and to estimate ORs and 95% CIs. Covariates were selected a priori based on clinical knowledge and the directed acyclic graph (DAG, Supplementary Figure 1). Model 1 adjusted for age, BMI, educational level, smoking, and alcohol consumption. Model 2 was an extended clinical model and additionally adjusted for sexual frequency, duration of infertility, chronic systemic disease, redundant foreskin, and varicocele. Model 1 was used for primary analyses; Model 2 was used for supplementary purposes to assess the robustness of the estimates in a more comprehensively adjusted clinical context. Given the cross-sectional design and uncertainty regarding the causal roles of chronic systemic diseases, results from Model 2 should be interpreted with caution. Additional analyses stratified by clinically relevant subgroups (age <30 vs ≥30 years; BMI <24 vs ≥24 kg/m²; education level; smoking status; alcohol consumption; infertility duration; sexual frequency; chronic disease; varicocele; and redundant foreskin) were undertaken to explore potential effect modification. Interaction P values were not adjusted for multiple testing and were interpreted cautiously. Because orchitis and seminal vesiculitis were uncommon, these conditions were included in descriptive and crude analyses but were not entered into the fully adjusted condition-specific models. All analyses were two-tailed, and statistical significance was set at P < 0.05. Data management and statistical computations were executed in R version 4.3.3 (R Foundation for Statistical Computing, Vienna, Austria).
Results
Of the 9345 participants included in the analysis, 1068 were in the LCS group and 8277 were in the non-LCS group (Table 1). The mean age of the participants was significantly higher in the LCS group (31.4 years ± 5.1) compared to the non-LCS group (30.7 years ± 4.9; P < 0.001). There was no significant difference in BMI between the LCS group (24.6 kg/m² ± 3.7) and the non-LCS group (24.6 kg/m² ± 3.5; P = 0.99). Smoking status differed significantly between the groups, with a higher proportion of smokers in the LCS group (49.3%) compared with the non-LCS group (43.6%; P < 0.001). No significant differences were found for alcohol consumption, educational level, sexual frequency, duration of infertility, varicocele, or redundant foreskin. The prevalence of chronic diseases was slightly higher in the LCS group (12.0%) compared to the non-LCS group (10.1%; P = 0.05). Epididymitis was more common in the LCS group (1.69%) compared to the non-LCS group (0.85%; P = 0.007). Similarly, prostatitis was more common in the LCS group (14.42%) compared to the non-LCS group (10.61%; P < 0.001). No significant differences were found in the prevalence of orchitis (P = 0.33) or seminal vesiculitis (P = 0.64).
Table 1
| Clinical characteristics | Total (n=9345) | Non-LCS (n=8277) | LCS (n=1068) | P |
|---|---|---|---|---|
| Age (years), mean ± SD | 30.8 ± 5.0 | 30.7 ± 4.9 | 31.4 ± 5.1 | < 0.001 |
| BMI (kg/m2), mean ± SD | 24.6 ± 3.5 | 24.6 ± 3.5 | 24.6 ± 3.7 | 0.99 |
| Lifestyle factors | ||||
| Smokinga, n (%) | < 0.001 | |||
|  Nonsmoker | 5209(55.7) | 4668(56.4) | 541(50.7) | |
|  Smoker | 4136(44.3) | 3609(43.6) | 527(49.3) | |
| Drinkingb, n (%) | 0.95 | |||
|  Nondrinker | 4339(46.4) | 3844(46.4) | 495(46.3) | |
|  Drinker | 5006(53.6) | 4433(53.6) | 573(53.7) | |
| Education, n (%) | 0.16 | |||
|  Middle school or lowerc | 2051(21.9) | 1804(21.8) | 247(23.1) | |
|  High school | 1672(17.9) | 1465(17.7) | 207(19.4) | |
|  College | 5622(60.2) | 5008(60.5) | 614(57.5) | |
| Sex frequency (weekly), n (%) | 0.42 | |||
|  < 1 | 1321 (14.1) | 1180 (14.3) | 141 (13.2) | |
|  1-2 | 5857(62.7) | 5192(62.7) | 665(62.3) | |
|  > 2 | 2167 (23.2) | 1905 (23.0) | 262 (24.5) | |
| Medical history | ||||
| Duration of infertility (year), n(%) | 0.89 | |||
|  < 1 | 4708 (50.4) | 4172 (50.4) | 536 (50.2) | |
|  ≥ 1 | 4637 (49.6) | 4105 (49.6) | 532 (49.8) | |
| Chronic diseasesd, n (%) No Yes | 8384(89.7) 961(10.3) | 7444(89.9) 833(10.1) | 940(88.0) 128(12.0) | 0.05 |
| Varicocele, n (%) | 0.39 | |||
|  No | 8728(93.4) | 7724(93.3) | 1004(94.0) | |
|  Yes | 617(6.6) | 553(6.7) | 64(6.0) | |
| Redundant foreskin, n (%) | 0.22 | |||
|  No | 6473(69.3) | 5716(69.1) | 757(70.9) | |
|  Yes | 2872(30.7) | 2561(30.9) | 311(29.1) | |
| Urogenital inflammation conditions | ||||
| Epididymitis, n(%) | 0.007 | |||
|  No | 9257 (99.1) | 8207 (99.2) | 1050 (98.3) | |
|  Yes | 88 (0.9) | 70 (0.8) | 18 (1.7) | |
| Prostatitis, n(%) | <0.001 | |||
|  No | 8313 (89.0) | 7399 (89.4) | 914 (85.6) | |
|  Yes | 1032 (11.0) | 878 (10.6) | 154 (14.4) | |
| Orchitis, n(%) | 0.33 | |||
|  No | 9287 (99.4) | 8228 (99.4) | 1059 (99.2) | |
|  Yes | 58 (0.62) | 49 (0.6) | 9 (0.8) | |
| Seminal vesiculitis, n(%) | 0.64 | |||
|  No | 9305 (99.6) | 8243 (99.6) | 1062 (99.4) | |
|  Yes | 40 (0.4) | 34 (0.4) | 6 (0.6) | |
Clinical characteristics of the 9345 subjects included in this study.
BMI, body mass index; SD, standard deviation.
P-values were calculated using the Student’s t-test, Kruskal-Wallis rank sum test or chi-square test.
included never smoking and no smoking during the past 3 months.
included never drinking and no drinking during the past 3 months.
included primary school and junior high school.
included diabetes, hypertension and dyslipidemia.
The semen parameters are also shown in Table 2. Compared with men without LCS, men with LCS had lower semen volume (2.8 vs 3.1 mL; P < 0.001), sperm concentration (56.7 vs 62.0 million/mL; P = 0.02), progressive motility (35.9% vs 38.1%; P < 0.001), total motility (41.0% vs 43.3%; P < 0.001), TMSC (55.2 vs 69.4 million; P < 0.001), and normal morphology (6.0% vs 7.0%; P = 0.01). The median concentration of leukocytes in semen was found to be higher in the LCS group than in the non-LCS group (2.3 × 106 cells/mL versus 0.1 × 106 cells/mL, P < 0.001). Men with LCS also had slightly lower sperm viability (72.0% vs 73.0%; P = 0.01) and higher DFI (15.2% vs 12.6%; P < 0.001) and HDS (7.6% vs 6.6%; P < 0.001). No significant difference was observed in AsAs (P = 0.14).
Table 2
| Semen parameters | Total (n=9345) | Non-LCS (n=8277) | LCS (n=1068) | P |
|---|---|---|---|---|
| Volume (mL), median (IQR) | 3.1 (2.2-4.2) | 3.1 (2.2-4.2) | 2.8 (2.0-3.9) | <0.001 |
| Concentration (million/mL), median (IQR) | 61.4 (31.1-110.9) | 62.0 (31.5-111.3) | 56.7 (27.6-105.4) | 0.02 |
| Progressive motility (%), median (IQR) | 37.8 (24.5-51.5) | 38.1 (24.8-51.8) | 35.9 (22.6-48.8) | <0.001 |
| Total motility (%), median (IQR) | 43.0 (28.1-57.9) | 43.3 (28.4-58.2) | 41.0 (26.5-55.6) | <0.001 |
| TMSC (million), median (IQR) | 67.5 (22.9-150.9) | 69.4 (23.9-154.2) | 55.2 (16.5-125.7) | <0.001 |
| Normal morphology (%), median (IQR; n) | 7.0 (5.0-8.0; 9255) | 7.0 (5.0-8.0; 8208) | 6.0 (4.0-8.0; 1047) | 0.01 |
| Leukocytes(×106/mL), median (IQR) | 0.1 (0-0.3) | 0.1 (0.0-0.2) | 2.3 (1.4-4.6) | <0.001 |
| AsAs (%), median (IQR; n) | 1.0 (0-3.0; 6579) | 1.0 (0.0-3.0; 5800) | 1.0 (0.0-3.0; 779) | 0.14 |
| Viability (%), median (IQR; n) | 73.0 (62.0-83.0; 3909) | 73.0 (62.0-84.0; 3441) | 72.0 (60.0-80.0; 468) | 0.01 |
| DFI (%), median (IQR; n) | 12.9 (8.3-19.7; 2183) | 12.6 (8.2-19.4; 1941) | 15.2 (9.6-23.8; 242) | <0.001 |
| HDS (%), median (IQR) | 6.7 (5.0-9.0; 2183) | 6.6 (4.9-8.8; 1941) | 7.6 (5.8-10.8; 242) | <0.001 |
Semen parameters of the 9345 subjects included in this study.
IQR, interquartile range; TMSC, total motile sperm count; AsAs, antisperm antibodies; DFI, DNA fragmentation index; HDS, high DNA stainability.
Logistic regression results are shown in Table 3. Each 1-year increase in age was associated with 2% higher odds of LCS (OR = 1.02, 95% CI: 1.01-1.04; P < 0.001), and smokers had higher odds of LCS than nonsmokers (OR = 1.26, 95% CI: 1.11-1.43; P < 0.001). A significant association was observed between urogenital inflammatory condition and LCS (OR = 1.48, 95% CI: 1.24-1.77; P < 0.001). Epididymitis (OR = 2.01, 95% CI: 1.19-3.39; P = 0.009), and prostatitis (OR = 1.42, 95% CI: 1.18-1.71; P < 0.001) were found to be independently associated with higher odds of LCS. No significant associations were found for BMI, alcohol consumption, educational level, sexual frequency, duration of infertility, varicocele, or redundant foreskin. The crude estimates for orchitis (OR = 1.43, 95% CI 0.70-2.91) and seminal vesiculitis (OR = 1.37, 95% CI 0.57-3.27) were imprecise.
Table 3
| Variables | β | SE | Z | OR (95% CI) | P |
|---|---|---|---|---|---|
| Age | 0.02 | 0.01 | 3.80 | 1.02 (1.01-1.04) | < 0.001 |
| BMI | -0.00 | 0.01 | -0.00 | 1.00 (0.98-1.02) | 0.99 |
| Smoking | |||||
| Nonsmoker | 1.00 (Reference) | ||||
| Smoker | 0.23 | 0.07 | 3.55 | 1.26 (1.11-1.43) | < 0.001 |
| Drinking | |||||
| Nondrinker | 1.00 (Reference) | ||||
| Drinker | 0.00 | 0.07 | 0.06 | 1.00 (0.88-1.14) | 0.95 |
| Education | |||||
| Middle school or lower | 1.00 (Reference) | ||||
| High school | 0.03 | 0.10 | 0.31 | 1.03 (0.85-1.26) | 0.75 |
| College | -0.11 | 0.08 | -1.38 | 0.90 (0.77-1.05) | 0.17 |
| Sex frequency (weekly) | |||||
| < 1 | 1.00 (Reference) | ||||
| 1-2 | 0.07 | 0.10 | 0.71 | 1.07 (0.88-1.30) | 0.48 |
| > 2 | 0.14 | 0.11 | 1.27 | 1.15 (0.93-1.43) | 0.20 |
| Duration of infertility (year) | |||||
| < 1 | 1.00 (Reference) | ||||
| ≥ 1 | 0.01 | 0.07 | 0.13 | 1.01 (0.89-1.15) | 0.89 |
| Chronic diseases | |||||
| No | 1.00 (Reference) | ||||
| Yes | 0.20 | 0.10 | 1.94 | 1.22 (1.00-1.48) | 0.05 |
| Varicocele | |||||
| No | 1.00 (Reference) | ||||
| Yes | -0.12 | 0.14 | -0.85 | 0.89 (0.68-1.16) | 0.39 |
| Redundant foreskin | |||||
| No | 1.00 (Reference) | ||||
| Yes | -0.09 | 0.07 | -1.21 | 0.92 (0.80-1.05) | 0.23 |
| Urogenital inflammation conditions | |||||
| No | 1.00 (Reference) | ||||
| Yes | 0.39 | 0.09 | 4.40 | 1.48 (1.24-1.77) | < 0.001 |
| Epididymitis | |||||
| No | 1.00 (Reference) | ||||
| Yes | 0.70 | 0.27 | 2.62 | 2.01 (1.19-3.39) | 0.009 |
| Prostatitis | |||||
| No | 1.00 (Reference) | ||||
| Yes | 0.35 | 0.09 | 3.72 | 1.42 (1.18-1.71) | < 0.001 |
| Orchitis | |||||
| No | 1.00 (Reference) | ||||
| Yes | 0.36 | 0.36 | 0.98 | 1.43 (0.70-2.91) | 0.33 |
| Seminal vesiculitis | |||||
| No | 1.00 (Reference) | ||||
| Yes | 0.31 | 0.44 | 0.71 | 1.37 (0.57-3.27) | 0.48 |
Logistic regression analyses for the relationship between clinical characteristics and LCS.
OR, Odds ratio; CI, Confidence interval.
Exploratory subgroup analyses were performed for epididymitis and prostatitis (Supplementary Figure 2). The overall associations were observed for both epididymitis (OR = 1.94, 95% CI 1.14-3.29; P = 0.014) and prostatitis (OR = 1.39, 95% CI 1.15-1.67; P < 0.001). No strong evidence of interaction was observed across the prespecified subgroups.
Multivariable logistic regression analyses revealed significant associations between specific urogenital inflammatory conditions and the likelihood of LCS (Table 4). For epididymitis, the aOR was 1.82 (95% CI 1.07-3.09; P = 0.03) in Model 1 and 1.88 (95% CI 1.10-3.21; P = 0.02) in Model 2. For prostatitis, the corresponding aORs were 1.37 (95% CI 1.13-1.65; P = 0.001) and 1.37 (95% CI 1.14-1.66; P < 0.001), respectively.
Table 4
| Urogenital inflammation conditions | Non-adjusted | Adjusted I | Adjusted II | |||
|---|---|---|---|---|---|---|
| OR (95% CI) | P | aOR (95% CI) | P | aOR (95% CI) | P | |
| Epididymitis | ||||||
|  No | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | |||
|  Yes | 2.01 (1.19-3.39) | 0.009 | 1.82 (1.07-3.09) | 0.03 | 1.88 (1.10-3.21) | 0.02 |
| Prostatitis | ||||||
|  No | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | |||
|  Yes | 1.42 (1.18-1.71) | < 0.001 | 1.37 (1.13-1.65) | 0.001 | 1.37 (1.14-1.66) | < 0.001 |
The association among epididymitis, prostatitis and LCS in 9345 males.
OR, Odds ratio; CI, Confidence interval; aOR, adjusted OR.
Adjusted I, adjusted age, BMI, smoking, alcohol consumption, education.
Adjusted II, adjusted age, BMI, smoking, alcohol consumption, education, sex frequency, duration of infertility, the presence of chronic diseases, redundant foreskin and varicocele.
Discussion
In this cross-sectional study of 9345 men attending an andrology clinic, we found that epididymitis and prostatitis were more common in men with LCS and were associated with higher odds of LCS after multivariable adjustment. Men with LCS were also slightly older, were more often smokers, and had lower semen volume, sperm concentration, progressive and total motility, TMSC, and normal morphology, together with higher DFI and HDS. Orchitis and seminal vesiculitis were uncommon, and the estimates for these conditions were imprecise. These findings describe cross-sectional associations and do not establish that the inflammatory conditions preceded LCS.
Previous studies have shown the correlation between demographic factors and lifestyle habits with leukocytospermia (Dutta et al., 2025). A study by Gill P. et al. included a total of 5435 IVF cycles for analysis and found that the LCS group had a significantly higher average age of 37.3 years, compared to 36.9 years in the non-LCS group (P = 0.004) (Gill et al., 2024). Similarly, our study also indicates that the leukocytospermia group being slightly older (LCS vs non-LCS, 31.4 vs 30.7). However, the absolute difference in our study was modest, and most participants were young men of reproductive age. Our data do not support a specific age-related immune mechanism. The proportion of smokers was also higher in the LCS group. A previous study in infertile men reported higher seminal leukocyte counts among cigarette smokers (Zhang et al., 2013). Cigarette smoke contains oxidant and toxic compounds, including polycyclic aromatic hydrocarbons and heavy metals, which may promote oxidative and inflammatory responses (Ilacqua et al., 2018). These compounds and inflammatory mediators were not measured in our study, and a biological mechanism cannot be inferred from the present data.
Prostatitis is a heterogeneous clinical syndrome, and bacterial prostatitis should be distinguished from chronic pelvic pain or inflammatory conditions without proven bacterial infection (Brunner et al., 1983; Nickel et al., 2001). The effect of prostatitis on conventional semen parameters remains controversial (Alshahrani et al., 2013). Several studies reported that chronic prostatitis negatively impact on semen quality (Menkveld et al., 2003; Marconi et al., 2009). However, other studies have failed to show significant differences in semen parameters between individuals with prostatitis and control groups (Pasqualotto et al., 2000; Ludwig et al., 2003). Indeed, Motrich et al. reported elevated levels of seminal leukocytes were detected in patients with chronic prostatitis (Motrich et al., 2005). In our study, prostatitis was associated with higher odds of LCS. However, semen parameters were compared between men with and without LCS, not between men with and without prostatitis. Our results therefore do not resolve whether prostatitis directly affects individual semen parameters.
Epididymitis, characterized by acute swelling of the scrotum, is caused by Chlamydia trachomatis or Neisseria gonorrhoeae in sexually active young men and by E. coli in older men (Ludwig, 2008). The inflammation may spread to the testes, causing epididymo-orchitis, which is linked to high infertility rates (Osegbe, 1991). Chronic epididymitis has been associated with lower sperm counts and motility (Haidl et al., 2008), and changes in sperm protein composition have been reported several months after acute epididymitis (Pilatz et al., 2014). In particular, the present study suggests that epididymitis is associated with higher odds of LCS, supporting an association between epididymal inflammation and increased seminal leukocytes. Orchitis, an inflammatory lesion of the testes, is caused by similar pathogens in men under 35 and by E. coli in older men (Henkel et al., 2021). Orchitis results in tubular damage and testicular atrophy, leading to poor sperm quality and low sperm counts (Schuppe et al., 2008). Seminal vesiculitis, an inflammatory condition in the male genital tract, is often characterized by hematospermia (Liu et al., 2016). Its prevalence is lower than that of other male genital tract inflammations such as prostatitis, epididymitis, and orchitis (Xu et al., 2011). While seminal vesiculitis is often self-limiting, it can persist as a refractory condition that causes anxiety and may negatively impact male fertility (Mathers et al., 2017). However, the current study did not find a significant association between orchitis and seminal vesiculitis and LCS, possibly due to the low prevalence of these conditions, which may have limited the statistical power to detect such associations. Collectively, these results highlight the clinical relevance of evaluating epididymitis and prostatitis in male infertility, as the presence of LCS may indicate underlying inflammatory processes that may negatively impact sperm quality and fertility outcomes.
The current study exhibits several strengths. The large sample size allowed us to examine several clinical and lifestyle factors in men undergoing andrological evaluation. Semen analyses were performed using standardized laboratory procedures, and one semen-analysis record was retained for each participant. In addition, the multivariable models included prespecified demographic, lifestyle, and clinical variables, and the DAG was used to make the covariate structure clear.
However, several limitations must be carefully considered. First, the cross-sectional design does not establish the temporal sequence between urogenital inflammatory conditions and LCS. Reverse causation and differences in symptom reporting or clinical assessment are possible. Second, epididymitis, prostatitis, orchitis, and seminal vesiculitis were clinically defined and were not confirmed by pathogen-specific culture or nucleic-acid testing. Misclassification of these conditions may therefore have occurred, and the direction of any resulting bias cannot be determined. Third, although we retained the semen analysis linked to the questionnaire and clinical assessment, LCS was classified from a single ejaculate. Within-person biological and analytical variation in seminal leukocyte concentration may have led to misclassification, particularly around the 1 × 106/mL threshold. Fourth, 3446 of the 12,791 initially screened records were excluded, mainly because of incomplete clinical information (n = 2903). Because most baseline and questionnaire variables were unavailable for these individuals, a comprehensive comparison between included and excluded participants could not be performed. Selection bias cannot be excluded if men with complete clinical information differed systematically from those with incomplete information. The analytical sample may therefore not fully represent all men attending the andrology clinic during the study period. Moreover, the cross-sectional design precludes establishing temporality, and thus the causal roles of chronic systemic diseases and varicocele could not be determined. Finally, residual confounding cannot be excluded, and the small numbers of men with orchitis or seminal vesiculitis limited the precision of the estimates for these conditions.
Conclusions
In summary, our study found that epididymitis and prostatitis were associated with higher odds of LCS in men attending an andrology clinic. Men with LCS had lower semen volume, sperm concentration, progressive and total motility, TMSC, and normal morphology, and higher DFI and HDS. These findings are relevant to the evaluation of men with LCS and suboptimal semen quality, but they do not establish causality or support empirical antibiotic treatment in the absence of confirmed infection. Prospective studies with repeated semen analyses, microbiological testing, and detailed assessment of genital tract inflammation are needed.
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding authors.
Ethics statement
The study protocol was reviewed and approved by the Institutional Review Board (Approval No. 2023-RE-196). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and institutional requirements.
Author contributions
NG: Writing – original draft, Writing – review & editing. ZZ: Writing – review & editing. ML: Writing – review & editing. QZ: Writing – review & editing. SB: Writing – review & editing, Writing – original draft. XH: Writing – review & editing.
Funding
This study was supported by the China Postdoctoral Science Foundation (2024M763169).
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2026.1890531/full#supplementary-material
Supplementary Figure 1Directed acyclic graph (DAG) of the hypothesized relationships between urogenital inflammatory conditions and LCS. Solid arrows represent the hypothesized relationships underlying Model 1. Dashed arrows represent clinically plausible relationships involving the additional covariates included in Model 2.
Supplementary Figure 2Stratified multivariate logistic regression of the associations among epididymitis, prostatitis and LCS according to subgroup analysis.
References
1
AlshahraniS.McGillJ.AgarwalA. (2013). Prostatitis and male infertility. J. Reprod. Immunol.100, 30–36. doi: 10.1016/j.jri.2013.05.004
2
AssidiM. (2022). Infertility in men: advances towards a comprehensive and integrative strategy for precision theranostics. Cells11, 1711. doi:Â 10.3390/cells11101711
3
BaiS.LiY.HuM. H.WuL.ShuiL. J.WangX. Het al. (2022). Association of sexually transmitted infection with semen quality in men from couples with primary and secondary infertility. Asian J. Androl.24, 317–322. doi: 10.4103/aja202164
4
BaiS.LiY.WanY.GuoT.JinQ.LiuR.et al. (2021). Sexually transmitted infections and semen quality from subfertile men with and without leukocytospermia. Reprod. Biol. Endocrinol.19, 92. doi:Â 10.1186/s12958-021-00769-2
5
BrunnerH.WeidnerW.SchieferH. G. (1983). Studies on the role of Ureaplasma urealyticum and Mycoplasma hominis in prostatitis. J. Infect. Dis.147, 807–813. doi: 10.1093/infdis/147.5.807
6
ChoiH. I.YangD. M.KimH. C.KimS. W.JeongH. S.MoonS. K.et al. (2020). Testicular atrophy after mumps orchitis: ultrasonographic findings. Ultrasonography39, 266–271. doi: 10.14366/usg.19097
7
DuttaS.BocuK.AgarwalA. (2025). Role of leukocytospermia in the management of male infertility: decoding a mystery for the busy clinicians. World J. Mens Health. 43, 465–476. doi: 10.5534/wjmh.240152
8
FanS.ZhaoY.ZhangZ.WangH.HouY.BaiS.et al. (2023). Effect of leukocytes on semen quality in men from primary and secondary infertile couples: a cross-sectional study. Health Sci. Rep.6, e1683. doi:Â 10.1002/hsr2.1683
9
FarielloR. M.Del GiudiceP. T.SpaineD. M.FraiettaR.BertollaR. P.CedenhoA. P. (2009). Effect of leukocytospermia and processing by discontinuous density gradient on sperm nuclear DNA fragmentation and mitochondrial activity. J. Assist. Reprod. Genet.26, 151–157. doi: 10.1007/s10815-008-9288-0
10
FraczekM.HryhorowiczM.GillK.ZarzyckaM.GaczarzewiczD.JedrzejczakP.et al. (2016). The effect of bacteriospermia and leukocytospermia on conventional and nonconventional semen parameters in healthy young normozoospermic males. J. Reprod. Immunol.118, 18–27. doi: 10.1016/j.jri.2016.08.006
11
GillP.PuchaltN. G.MolinaroT.WernerM.SeliE.HotalingJ.et al. (2024). Leukocytospermia does not negatively impact outcomes in in vitro fertilization cycles with intracytoplasmic sperm injection and preimplantation genetic testing for aneuploidy: findings from 5435 cycles. J. Assist. Reprod. Genet.41, 1213–1219. doi: 10.1007/s10815-024-03085-x
12
HaidlF.HaidlG.OltermannI.AllamJ. P. (2015). Seminal parameters of chronic male genital inflammation are associated with disturbed sperm DNA integrity. Andrologia47, 464–469. doi: 10.1111/and.12408
13
HaidlG.AllamJ. P.SchuppeH. C. (2008). Chronic epididymitis: impact on semen parameters and therapeutic options. Andrologia40, 92–96. doi: 10.1111/j.1439-0272.2007.00819.x
14
HenkelR.OfforU.FisherD. (2021). The role of infections and leukocytes in male infertility. Andrologia53, e13743. doi:Â 10.1111/and.13743
15
IlacquaA.IzzoG.EmerenzianiG. P.BaldariC.AversaA. (2018). Lifestyle and fertility: the influence of stress and quality of life on male fertility. Reprod. Biol. Endocrinol.16, 115. doi:Â 10.1186/s12958-018-0436-9
16
LiuB.SongZ.SuS.TangM.XuA.SongN.et al. (2016). Abnormal expression of Sg I is closely related to seminal vesiculitis. Urology88, 227.e9–227.e14. doi: 10.1016/j.urology.2015.08.031
17
LudwigM. (2008). Diagnosis and therapy of acute prostatitis, epididymitis and orchitis. Andrologia40, 76–80. doi: 10.1111/j.1439-0272.2007.00823.x
18
LudwigM.VidalA.HuweP.DiemerT.PabstW.WeidnerW. (2003). Significance of inflammation on standard semen analysis in chronic prostatitis/chronic pelvic pain syndrome. Andrologia35, 152–156. doi: 10.1046/j.1439-0272.2003.00553.x
19
MarconiM.PilatzA.WagenlehnerF.DiemerT.WeidnerW. (2009). Impact of infection on the secretory capacity of the male accessory glands. Int. Braz. J. Urol.35, 299–308. doi: 10.1590/s1677-55382009000300006
20
MathersM. J.DegenerS.SperlingH.RothS. (2017). Hematospermia-a symptom with many possible causes. Dtsch. Arztebl Int.114, 186–191. doi: 10.3238/arztebl.2017.0186
21
MenkveldR.HuweP.LudwigM.WeidnerW. (2003). Morphological sperm alternations in different types of prostatitis. Andrologia35, 288–293. doi: 10.1046/j.1439-0272.2003.00574.x
22
MoilanenJ. M.CarpenO.HovattaO. (1998). Flow cytometric light scattering analysis, acrosome reaction, reactive oxygen species production and leukocyte contamination of semen preparation in prediction of fertilization rate in vitro. Hum. Reprod.13, 2568–2574. doi: 10.1093/humrep/13.9.2568
23
MotrichR. D.MaccioniM.MolinaR.TisseraA.OlmedoJ.RieraC. M.et al. (2005). Reduced semen quality in chronic prostatitis patients that have cellular autoimmune response to prostate antigens. Hum. Reprod.20, 2567–2572. doi: 10.1093/humrep/dei073
24
NickelJ. C.DowneyJ.HunterD.ClarkJ. (2001). Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J. Urol.165, 842–845. doi: 10.1016/s0022-5347(05)66541-x
25
OsegbeD. N. (1991). Testicular function after unilateral bacterial epididymo-orchitis. Eur. Urol.19, 204–208. doi: 10.1159/000473620
26
PasqualottoF. F.SharmaR. K.PottsJ. M.NelsonD. R.ThomasA. J.AgarwalA. (2000). Seminal oxidative stress in patients with chronic prostatitis. Urology55, 881–885. doi: 10.1016/s0090-4295(99)00613-5
27
PellatiD.MylonakisI.BertoloniG.FioreC.AndrisaniA.AmbrosiniG.et al. (2008). Genital tract infections and infertility. Eur. J. Obstet. Gynecol Reprod. Biol.140, 3–11. doi: 10.1016/j.ejogrb.2008.03.009
28
PilatzA.LochnitG.KarnatiS.Paradowska-DoganA.LangT.SchultheissD.et al. (2014). Acute epididymitis induces alterations in sperm protein composition. Fertil. Steril.101, 1609–1617. doi: 10.1016/j.fertnstert.2014.03.011
29
RiveroM. J.KulkarniN.ThirumavalavanN.RamasamyR. (2023). Evaluation and management of male genital tract infections in the setting of male infertility: an updated review. Curr. Opin. Urol.33, 180–186. doi: 10.1097/mou.0000000000001081
30
SchuppeH. C.MeinhardtA.AllamJ. P.BergmannM.WeidnerW.HaidlG. (2008). Chronic orchitis: a neglected cause of male infertility? Andrologia40, 84–91. doi: 10.1111/j.1439-0272.2008.00837.x
31
SharmaR.GuptaS.AgarwalA.HenkelR.FinelliR.ParekhN.et al. (2022). Relevance of leukocytospermia and semen culture and its true place in diagnosing and treating male infertility. World J. Mens Health40, 191–207. doi: 10.5534/wjmh.210063
32
SukcharoenN.KeithJ.IrvineD. S.AitkenR. J. (1995). Predicting the fertilizing potential of human sperm suspensions in vitro: importance of sperm morphology and leukocyte contamination. Fertil. Steril.63, 1293–1300. doi: 10.1016/s0015-0282(16)57614-6
33
World Health Organization (2010). WHO Laboratory Manual for the Examination and Processing of Human Semen. 5th ed (Geneva: World Health Organization).
34
XuB.NiuX.WangZ.LiP.QinC.LiJ.et al. (2011). Novel methods for the diagnosis and treatment of ejaculatory duct obstruction. BJU Int.108, 263–266. doi: 10.1111/j.1464-410x.2010.09775.x
35
ZhangZ. H.ZhuH. B.LiL. L.YuY.ZhangH. G.LiuR. Z. (2013). Decline of semen quality and increase of leukocytes with cigarette smoking in infertile men. Iran. J. Reprod. Med.11, 589–596.
Summary
Keywords
epididymitis, leukocytospermia, prostatitis, seminal leukocytes, urogenital inflammation conditions
Citation
Guo N, Zhang Z, Li M, Zhang Q, Bai S and He X (2026) Association between urogenital inflammation conditions and leukocytospermia: insights from a large-scale cross-sectional study. Front. Cell. Infect. Microbiol. 16:1890531. doi: 10.3389/fcimb.2026.1890531
Received
25 May 2026
Revised
18 July 2026
Accepted
20 July 2026
Published
12 August 2026
Volume
16 - 2026
Edited by
Ugochukwu Offor, Queen Mary University of London, United Kingdom
Reviewed by
Kostadin Kostadinov, Plovdiv Medical University, Bulgaria
Kutullo Mohlala, University of the Western Cape, South Africa
Updates
Copyright
© 2026 Guo, Zhang, Li, Zhang, Bai and He.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Shun Bai, shunbai@ustc.edu.cn; Xiaojin He, hxj0117@126.com
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.